[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Viking Therapeutics, Inc](/topic/$vktx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +18%  
**6 Months**: XX% +19%  
**1 Year**: XX% +16%  
**1-Year High**: XX% on 2025-10-27  
**1-Year Low**: XX% on 2025-02-08  

**Most Supportive Themes**
- **Buyout/Partnership Speculation:** (45%) Posts suggest Viking Therapeutics ($VKTX) is a potential acquisition target or will form a partnership, fueled by the recent Pfizer/Metsera deal and the company's promising obesity drug.
- **Positive Data and Market Potential:** (30%) The positive Phase X data for VK2735, the oral dual agonist, and the overall growth of the obesity treatment market are driving optimism.
- **Comparison to Competitors:** (15%) Comparisons to major players like Lilly ($LLY) and Novo Nordisk ($NVO) highlight the potential of $VKTX in the obesity market.
  
**Most Critical Themes**
- **Data Analysis and Valuation:** (10%)  Some posts analyze the Phase X data and discuss the valuation of $VKTX, with some suggesting the current market cap may not justify a high buyout price.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %  | Negative | %  |
| ------- | -------- | -  | ------- | -  | -------- | -  |
| Reddit  | X        | X% |         |    |          |    |
| TikTok  | X        | X% | XX      | X% |          |    |
| X       | XX       | X% | XXX     | X% | XXX      | X% |
| YouTube | X        | X% |         |    |          |    |
|         |          |    |         |    |          |    |
| Total   | XXX      | X% | XXX     | X% | XX       | X% |